Empagliflozin vs Imatinib

Empagliflozin vs Imatinib: Overview

This comparison examines the pharmacological differences between Empagliflozin and Imatinib.

Mechanism of Action

Empagliflozin: Selective SGLT2 inhibitor reducing renal glucose reabsorption.

Imatinib: Selective inhibitor of BCR-ABL, c-Kit, and PDGFR tyrosine kinases.

Pharmacokinetics

Half-life: Empagliflozin — 12.4 hours; Imatinib — 18 hours.

Chemical Properties

Molecular Formula: Empagliflozin — C23H27ClO7; Imatinib — C29H31N7O.

Molecular Weight: Empagliflozin — 450.9100 g/mol; Imatinib — 493.6030 g/mol.

Type: Empagliflozin — Small molecule; Imatinib — Small molecule.